packageSirukumab

sirukumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sirukumab, a monoclonal antibody interleukin inhibitor, was investigated for treating rheumatoid arthritis. It was never approved; its marketing application in the European Union was withdrawn, so it remains investigational.

Summary written by glm-5.3-flash from Wikidata Q7530673 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sirukumab
ATC codes:L04AC15
DrugBank:DB11803
Wikidata:Q7530673

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown